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Abstract
Introduction: Cartilage thickness from MR images has been identified as a possible biomarker in knee osteoarthritis
(OA) research. The ability to acquire MR data at multiple centers by using different vendors’ scanners would facilitate
patient recruitment and shorten the duration of OA trials. Several vendors manufacture 3T MR scanners, including
Siemens, Philips Medical Systems, and GE Healthcare. This study investigates whether quantitative MR assessments of
cartilage morphology are comparable between scanners of three different vendors.
Methods: Twelve subjects with symptoms of knee OA and one or more risk factors had their symptomatic knee
scanned on each of the three vendor’s scanners located in three sites in the UK: Manchester (Philips), York (GE),
and Liverpool (Siemens). The NIH OAI study protocol was used for the Siemens scanner, and equivalent protocols
were developed for the Philips and GE scanners with vendors’ advice. Cartilage was segmented manually from
sagittal 3D images. By using recently described techniques for Anatomically Corresponded Regional Analysis of
Cartilage (ACRAC), a statistical model was used anatomically to align all the images and to produce detailed maps
of mean differences in cartilage-thickness measures between scanners. Measures of cartilage mean thickness were
computed in anatomically equivalent regions for each subject and scanner image.
Results: The ranges of mean cartilage-thickness measures for this cohort were similar for all regions and across all
scanners. Philips intrascanner root-mean-square coefficients of variation were low in the range from 2.6% to 4.6%.
No significant differences were found for thickness measures of the weight-bearing femorotibial regions from the
Philips and Siemens images except for the central medial femur compartment (P = 0.04). Compared with the other
two scanners, the GE scanner provided consistently lower mean thickness measures in the central femoral regions
(mean difference, -0.16 mm) and higher measures in the tibial compartments (mean difference, +0.19 mm).
Conclusions: The OAI knee-imaging protocol, developed on the Siemens platform, can be applied to research and
trials by using other vendors’ 3T scanners giving comparable morphologic results. Accurate sequence optimization,
differences in image postprocessing, and extremity coil type are critical factors for interscanner precision of
quantitative analysis of cartilage morphology. It is still recommended that longitudinal observations on individuals
should be performed on the same scanner and that assessment of intra- and interscanner precision errors is
undertaken before commencement of the main study.
* Correspondence: sharana@doctors.org.uk
1Biomedical Imaging Institute, The University of Manchester, Oxford Road,
Manchester, M13 9PT, UK
Full list of author information is available at the end of the article
Balamoody et al. Arthritis Research & Therapy 2010, 12:R202
http://arthritis-research.com/content/12/5/R202
© 2010 Balamoody et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Introduction
Osteoarthritis (OA) is a major and increasing public health
problem in the developed world. The present National
Institutes of Health Osteoarthritis Initiative (NIH OAI) is
a prospective ongoing 9-year study of approximately 5,000
subjects, investigating subjects both with OA and at risk of
developing OA to identify measures of OA initiation and
progression [1]. Cartilage thickness and volume measure-
ments from MR images are potential morphologic biomar-
kers for OA that can be assessed from MR images,
acquired annually on all subjects in the OAI. Such
measures could be used as response biomarkers in the
development of therapies for OA, particularly in Phase II
clinical trials. All MR images in the OAI are acquired on
four Siemens 3.0T MR scanners.
Recent analyses of small initial OAI cohorts suggest car-
tilage loss in OA to be in the range of 0.5% to 2.0% per
annum [2]. Obesity, malalignment, and radiographic OA
Kellgren and Lawrence grades 2 to 3 predispose to higher
rates of cartilage loss [2-4]. Several factors can influence
reproducibility of quantitative measurement of cartilage
thickness between groups (for example, age and sex) and
within groups (for example, recent weight-bearing activity,
diurnal variation [5,6]). Phase II clinical studies of cartilage
loss in OA are likely to require a multicenter approach to
recruit sufficient numbers of subjects in a reasonable time
with adequate statistical power. Most MR scanners are
produced by one of three main vendors: Philips (Eindho-
ven, The Netherlands), Siemens (Erlangen, Germany), and
GE Healthcare (Milwaukee, Wisconsin, USA). Multicenter,
multivendor clinical studies of OA performed at 3.0T have
been published [7]. Although evidence suggests that inter-
scanner differences in cartilage volume in healthy subjects
are small [8], little evidence indicates that quantitative ana-
lyses of degenerating cartilage on scanners of different
vendors are comparable in symptomatic subjects and at
higher field strength [9,10].
The study described is a cross-sectional comparison of
three 3.0T MR scanners of different manufacturers in the
assessment of OA of the knee in a cohort of subjects with
symptoms and risk factors for OA. The 3.0T scanners used
are manufactured by Philips, Siemens, and GE. The imaging
protocols are based on the Siemens NIH OAI protocol,
which assesses several features of OA. A quantitative carti-
lage-morphology analysis is presented. The objectives were
to quantify the interscanner precision errors and to assess
whether these were significant by comparing with the
intrascanner variability (assessed on the Philips scanner).
Materials and methods
Subjects
Participants were recruited from the University of Man-
chester employee base by a universal email sent to all
employees. Interested responders were subsequently
sent an information sheet and a screening questionnaire.
The questionnaire was designed to include contact
information, demographics, and assessment of inclusion
and exclusion criteria, which were based on those
quoted in the NIH OAI protocol [11]. Subjects were
required to have one or more symptoms of OA or one
or more risk factors for OA or both. OA symptom cri-
teria included pain, stiffness, locking (or requiring
analgesia for symptoms) within the last month. Risk-
factor criteria were obesity, family history of osteoarthri-
tis, previous knee injury, and frequent knee-bending
activity. Responders were excluded if they indicated defi-
nite or suspected history of inflammatory arthropathy or
had contraindications to MR scanning. Suitable respon-
ders were invited for an MR scan. Informed consent
was obtained from each participant. Ethical approval for
the study was obtained from West Midlands Multi-Cen-
tre Research Ethics Committee (06/MRE07/16).
Seventeen subjects (12 men, five women) were initially
recruited. Five of these subjects did not complete imaging
at all three sites. Two of these five attended but failed to
be scanned at one of the sites because of inadequate knee
RF coil diameter, and therefore discontinued the study at
that point. The other three subjects chose to withdraw
before attending all three sites. Data acquired if subjects
had not attended one or two of the sites was excluded
from analysis, and therefore, t h ed a t af o rt h e1 2s u b j e c t s
who had been scanned at all three sites were analyzed.
Demographics for this cohort n =1 2a sf o l l o w s :n i n e
men, three women, aged 49.3 ± 10.0, 32 to 58 years
(mean ± standard deviation, range) and BMI 28.3 ± 6.2,
22.1 to 44.2 kg/m
2.F i v eo f1 2s u b j e c t sh a dk n e ep a i no n
activity or rest or both for at least 7 days in the last
month at the time of completing the questionnaire; the
other seven subjects experienced pain less frequently.
Three subjects previously had received a diagnosis of OA.
Although radiographic data were not available to
demonstrate the presence of definite OA features, such
as joint-space loss and osteophytes, for volunteer selec-
tion, as in the NIH study, semiquantitative knee scoring
by using Whole-Organ Magnetic Resonance Score
(WORMS) [12] was performed by a single observer (SB)
on the acquired MR data. The WORMS involves divid-
ing the total knee cartilage into 14 subregions (4 points
for the patellofemoral (PF) joint; 5, for medial tibiofe-
moral (MTF) joint; and 5 for lateral tibiofemoral (LTF)
joint). The cartilage in each subregion is scored from 0
to 6; 0 = normal cartilage; 6 = diffuse full-thickness car-
tilage loss. Then the relevant subregions are summed to
obtain compartmental scores. With WORMS, maximal
compartmental values obtainable would be 30, 30, and
12 for the MTF, LTF, and PF joints, respectively.
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The Siemens sequences were based on the NIH OAI
protocol [11], whereas optimized protocols were
obtained for the Philips and GE scanners. This was
done with the help of clinical scientists specializing in
musculoskeletal MR from Philips (Netherlands) and GE
(UK). A summary of Siemens 3D DESS-we, and equiva-
lent sequence parameters on the other scanners is given
in Table 1. A notable difference is apparent with the GE
sequence, which uses fat saturation in place of water-
excitation and also has a lower acquired resolution. Phi-
lips uses a higher TE/TR compared with the other two
scanners (9/20 ms versus 4/16 ms).
The three 3.0T MR scanners were located as follows:
Philips Achieva (Manchester, UK), Siemens Trio (MAR-
I A R C ,L i v e r p o o l ,U K ) ,a n dG ES i g n a( Y N I C ,Y o r k ,U K ) .
The Siemens and GE coils used were quadrature circularly
polarized transmit-receive and single-channel transmit-
receive multipurpose HD knee/foot coil, respectively. An
eight-channel SENSE phased-array receive coil was used
at the Philips site. The SENSE function on the Philips coil
was implemented for certain sequences only.
Data acquisition
Each subject was designated to have the same knee
examined on each of the three different vendors, and, at
the Philips 3.0T scanner, an additional examination at
the same visit. Before scanning at each center, each sub-
j e c tu n d e r w e n tam i n i m u mr e s tp e r i o do fn o n - w e i g h t
bearing of at least 30 minutes to minimize variability in
cartilage thickness between scans due to recent weight-
bearing activity. It was not possible totally to control for
within-subject diurnal variation in cartilage thickness
between scans because of constraints on scanner and
subject availability. Scan times for the OAI protocol
(which comprised five acquisition sequences imaging the
knee) at the Siemens, Philips, and GE scanners were
37 minutes 41 seconds, 39 minutes 9 seconds, and 41
minutes, respectively. At the Philips site, the sagittal 3D
WATSf was acquired twice within the same session to
assess intrascanner precision. After the first acquisition,
the subject was removed from the magnet bore and
allowed to sit on the scan table without weight bearing
for approximately 10 to 15 minutes and repositioned for
the second acquisition.
Efforts were made to ensure similar orientation of slices
between scanners as follows. The planning for the first
sagittal and coronal sequences was applied to subsequent
sequences for each scan at each center. After the first of
the three scans, the overlays of the scout views for sagittal
and coronal images were saved and used for comparison
for planning subsequent scans of the same subject on the
other two scanners. Images at each of the sites were
labeled with a unique study number randomized inde-
pendently at each site so that observers would be blind to
subject identity for each of the scanners. Blinding to
scanner was not performed, as scanners could be easily
identified from the images by their appearance.
Quality assurance
The routine quality assurance (QA) at each scanner site
was recorded as follows. At the GE site, magnet SNR
checks were performed on alternate days. No other
documented quality control was available.
At the Siemens site, monthly/2-monthly QA reports
were documented, including SNR, gradient sensitivity,
and fat/water saturation checks. Some of the QA for the
Siemens site was performed remotely.
At the Philips site, daily checks were performed by the
radiographers. A dedicated employee responsible for
scanner QA was available to perform checks by using
phantoms investigating geometric distortion, SNR, RF
uniformity, and slice profile. Most of the tests were
stable. Regarding geometric distortion, slight drift was
observed in the craniocaudal direction (-0.1% to 0.2%)
over the time course of the study. RF coil SNR checks
were performed only occasionally at all sites.
Cartilage segmentation
In total, 48 scans were included in the cartilage mor-
phology analysis: 12 subjects × four scans (three sites +
extra 3D WATSf dataset acquired at Philips scanner).
The cartilage was manually segmented from the sagittal
3D sequences by a single observer (author 1) blinded to
subject identity, by using the Endpoint segmentation
software (Imorphics, Manchester, UK), which imple-
ments a livewire algorithm [13]. Quality control of all
Table 1 Summary of sequence parameters for the
Siemens OAI protocol and optimized equivalent
protocols for the GE and Philips 3.0T scanners
Vendor Siemens Philips GE
Sequence 3D DESS 3DWATSf 3D GE
Fat saturation/water
excitation (WE)
WE WE Fat sat
FOV (mm) 140 140 140
Number of slices 160 120 210
Slice thickness (mm) 0.7 0.7 1
Slice gap (mm) 0 0 -0.5
Flip angle (deg) 25 25 25
TE (ms) 4.7 9.2 4.9
TR (ms) 16.3 20 16.8
X-resolution (mm) 0.37 0.36 0.55
Y-resolution (mm) 0.46 0.48 0.62
Scan time 10 min 35 s 3 min 51 s 6 min 22 s
D.ESS, dual-echo steady state; GE, gradient echo; WATSf, water selective
(fluid).
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tant musculoskeletal radiologist (last author). Closed-
surface representations of the cartilage sheets were
generated from the segmentations to enable volume and
thickness to be measured in 3D.
Defining a common frame of reference: bone reference
surfaces
To compare measurements of cartilage thickness from
images of the same subject taken with different scan-
ners, and to enable aggregation of measures over the
study cohort, an anatomic frame of reference was
defined in each image by using recently described tech-
niques for Anatomically Corresponded Regional Analy-
sis of Cartilage (ACRAC) [14]. The exosteal bone
surface was chosen as a basis for the frame of reference
because of the relative ease of its identification in the
images and consistent topology across subjects. Six
regions were defined on this surface; these were used
for the analysis (see Figure 1). Statistical models were
used as a means of defining the bone reference surface
in each image [15]. The models provide a mean repre-
sentation of all the training-set images and a warp from
the mean image to each example image. When pre-
sented with new MR images, which were not part of the
original training set, statistical models can also automa-
tically find the best warp field from the mean image.
A statistical model was b u i l tf r o mt h eD E S S - w e
images of both knees fromthe 160 participants initially
released by the OAI as group 0.B.1, which included a
single time point only and both knees of participants
[ 1 ] .T h ee x o s t e a lb o n eb o u n d a r yw a ss e g m e n t e db ya
consultant musculoskeletal radiologist (last author) in
the mean model image, and a surface representation
was generated. The warp fields from the mean image to
the study images were found by the model and used to
propagate the bone reference surface, thus providing
anatomically coherent bone segmentations for each
scan.
Cartilage morphology measures
The bone reference surfaces provided a dense set of
points with mean separation of 0.6 mm on the distal
femur and proximal tibia. Cartilage thickness was mea-
sured above each point in each image as the distance
between the points of intersection of the 3D line, nor-
mal to the bone reference surface, with the inner and
outer cartilage surfaces. The result is a cartilage-thick-
ness measurement associated with each measurement
point, which was displayed as a color-coded map of car-
tilage thickness on each reference bone surface.
From the individual cartilage-thickness maps, sum-
mary measures of cartilage morphology measures within
anatomically consistent regions were computed to
enable us to perform statistical analysis of the differ-
ences. From the bone reference surface, regions of inter-
est, consistent with those proposed by Eckstein et al.
[16] were delineated on the mean distal femoral and
proximal tibial bone surfaces. Mean cartilage thickness
over total bone area (ThCtAB, as defined by Eckstein
et al. [16]), was computed for all regions as the average
o ft h ep o i n t - w i s et h i c k n e s smeasurements weighted by
the area surrounding each measurement point. These
regions by definition do not exclude any areas denuded
of cartilage. Peripheral cartilage is more prone to seg-
mentation error due to partial volume effect, as the
Figure 1 Anatomic regions of interest illustrated on the mean bone shape.A l lr e g i o n sa r et r i m m e dt oe x clude the periphery of the
cartilage. Two regions are defined within both femoral condyles: the full region extending to the posterior of the joint; and central (c), restricted
to the main load-bearing regions.
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other authors [17,18], we remove the outer edges of car-
tilage coverage by defining trimmed regions for each
joint. Figure 1 illustrates the six regions of interest, trim-
ming boundary, and identifying labels, as shown on the
mean bone surfaces. This technique has been described
in detail by Williams et al. [19].
Population and difference maps
The correspondence of the cartilage-thickness maps
between scan sessions and across subjects enables us to
aggregate the individual subjects’ thickness maps to a
mean cohort-thickness map for each scanner. Individual
maps could be constructed to demonstrate the point-wise
differences in thickness between scanner pairs, and these
are also combined to form mean cartilage-thickness differ-
ence maps for the cohort. These population-difference
maps were displayed on the mean bone shape, from which
more-localized regional measures could be performed.
Statistical analysis
The study provided data for the reproducibility analysis
of regional cartilage mean thickness between scanners
(interscanner) and within the Phillips scanner (intrascan-
ner). Image data from the first scan of the two taken at
the Philips site were used only for the interscanner analy-
sis. Intra- and interscanner precision was evaluated with
Bland-Altman analysis, paired t tests, and coefficient of
variation (COV), aggregated as the root-mean-square
over all subjects for scanners pairs and expressed as a
percentage [20]. Bland-Altman analysis provides the ‘bias’
(mean difference) and its limits of agreement between
any pairs of measurements [21].
Results
All data were acquired within a 4½-month period. The
duration between first and last scans for a single subject
was 74 ± 35 days; range, 13 to 123 days. Results of the
semiquantitative cartilage scoring by WORMS [12]
demonstrated a large range of changes within the
cohort. Mean cartilage scores for the MTF, LTF, and PF
compartments for the cohort were 5.7 ± 5.9, 3.6 ± 4.7,
and 7.0 ± 5.1, respectively (Philips scanner) [22]. Sub-
jects demonstrated a broad range of OA pathology,
from mild cartilage abnormalities to full-thickness carti-
lage loss and subchondral changes.
Intrascanner precision
The Philips intrascanner COVs based on the two scans
were in the range 2.6% to 4.6%. Low variability is also
depicted by the Bland-Altman analysis, which produced
mean differences of magnitude ≤0.05 mm and tight 95%
limits of agreement of magnitude <0.35 mm and no sig-
nificant differences between the two scans (paired t test,
P > 0.05) for all regions except the MF region, for
which the difference was small at 0.05 mm (Table 2).
Interscanner precision
For the three scanner pairs, interscanner cartilage
volume COVs were on average 2.3% higher than thick-
ness values for the six regions. Overall, the comparison
of the Philips and Siemens scanners gave values similar
to those of the Philips intrascanner. The Philips 3D
WATSf mean cartilage-thickness measures were
≤0.06 mm thicker across all four main weight-bearing
regions (cMF, cLF, LT, and MT) compared with the 3D
DESS (Siemens). These small differences were nonsigni-
ficant (paired t test, P > 0.05), except for the central
medial femur, the result of which can mostly be attribu-
ted to an outlier measurement of abnormally thin carti-
lage in the Siemens scan of one of the subjects.
More pronounced differences in cartilage-thickness
measurements were found on the GE scanner compared
with the other two vendors’ s c a n n e r s ,a si se v i d e n ti n
Figure 2. Measures of the mean thickness in the central
femur regions were consistently lower on the GE scanner
(average bias, 0.13 mm over the four femoral regions and
both scanner pairs) and consistently higher in the tibial
compartments (average bias, 0.19 mm). Significant inter-
scanner differences were found for several regions, espe-
cially when compared with the Philips data (P < 0.05).
Thickness-difference maps
The spatial distribution of differences between scanners
is visualized on the mean cartilage-difference thickness
maps in Figure 3. The differences are shown by using a
consistent red-to-blue scale for all four comparison
plots. In general, the largest variability is exhibited at
the periphery of the cartilage coverage. The paler-color
map for the Philips intrascanner differences reflects the
lower variability compared with the interscanner maps.
The Philips and Siemens scans showed higher values for
femoral cartilage thickness compared with GE, whereas
this pattern was reversed in the tibia.
Discussion
The current interest in multicenter trials using MR-
imaging biomarkers to measure OA progression [7]
requires investigation and optimization of interscanner
precision errors. Multicenter trials using 3.0T scanners
may require using scanners of different vendors, and
therefore acquisition sequences and hardware may differ
between sites. This study is the first to compare repeated
measures of cartilage morphology from 3.0T MR scan-
ners of three different vendors on symptomatic subjects.
Intrascanner cartilage mean thickness coefficients of var-
iation on the Philips scanner in this study are in the range
2.6% to 4.6%, which is in line with other intrascanner
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the Philips and Siemens scanners demonstrated small sys-
tematic differences in regional cartilage-thickness mea-
surements that were comparable with the intrascanner
precision errors. The results compare favorably with those
of the previous multivendor study by Morgan et al.[ 8 ] ,
which measured knee-cartilage volume in healthy subjects
at 1.0 to 1.5T, where interscanner volume COVs were in
the range 9.0% to 18.7%. This can be explained by the
increased SNR, which allowed resolution to be almost
doubled in each plane, reducing partial-volume effects. In
our study, intrascanner cartilage-volume COVs produced
very similar values to the thickness COVs, whereas inter-
scanner volume COVs were on average 2.3% higher for
the given regions. Volume COVs are a function of variabil-
ity of both thickness and surface area, thus providing lim-
ited information on sources of variability in precision
errors and therefore not reported in detail here.
The higher interscanner variability measured between
Philips and GE can be explained by both hardware and
sequence differences. Difficulties were encountered
in mimicking the DESS sequence on the GE platform.
Increased image noise and differences in sequences
(water-excitation on Philips versus fat-saturation on
GE) may have an effect on the cartilage boundaries.
Comparisons of these sequences have demonstrated
apparently thicker cartilage in the water-excitation
images, although the differences were in the range of
Table 2 Results of Philips intrascanner and vendor interscanner comparisons
Scanner pair Region RMS COV Mean difference/bias (mm) 95% limits of agreement (mm) Paired t test
Lower bound Upper bound P value
Philips first to second scan(intrascanner) cLF 2.6% 0.00 -0.19 0.20 0.95
cMF 3.2% 0.03 -0.14 0.20 0.23
LT 4.1% -0.05 -0.34 0.25 0.30
MT 4.6% 0.00 -0.30 0.30 0.98
LF 3.6% 0.00 -0.23 0.23 0.98
MF 2.8% 0.05 -0.08 0.18 0.02
a
Philips to Siemens cLF 4.1% 0.06 -0.13 0.25 0.10
cMF 5.4% 0.05 -0.19 0.30 0.04
a
LT 4.0% 0.06 -0.10 0.22 0.75
MT 5.6% 0.05 -0.33 0.43 0.30
LF 4.9% 0.13 -0.04 0.30 0.00
a
MF 5.8% 0.08 -0.12 0.29 0.00
a
Siemens to GE cLF 5.1% 0.12 -0.11 0.36 0.00
a
cMF 5.6% 0.13 -0.06 0.31 0.00
a
LT 7.7% -0.24 -0.55 0.06 0.00
a
MT 7.7% -0.17 -0.51 0.18 0.01
a
LF 4.2% 0.04 -0.20 0.27 0.28
MF 5.2% 0.01 -0.25 0.26 0.85
Philips to GE cLF 6.6% 0.18 -0.03 0.39 0.00
a
cMF 9.6% 0.21 -0.03 0.46 0.00
a
LT 8.1% -0.23 -0.60 0.13 0.00
a
MT 5.4% -0.12 -0.34 0.11 0.00
a
LF 7.2% 0.17 -0.14 0.47 0.00
a
MF 7.3% 0.14 -0.14 0.42 0.00
a
aP < 0.05 (between-scanner differences are significant). The Bland-Altman plots (not shown) showed no relations between mean and difference of per-subject
measures of regional cartilage thickness. cLF, central lateral femur; cMF, central medial femur; LF, lateral femur; LT, lateral tibia; MF, medial femur; MT, medial
tibia; RMS COV, root-mean-square coefficient of variation.
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Figure 2 Mean and 95% confidence interval (CI) for mean
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were similar, subjectively, the GE images appeared
more noisy. Poststudy examination of the images
revealed that the cartilage-to-bone boundary was sub-
jectively less pronounced on the GE scanner compared
with the Philips scanner and that, when comparing
images of the same subjects, in some cases, the
femoral cartilage appeared thinner. Partial-volume
errors are consequently likely to have been greater.
With respect to segmentation of the sagittal 3D
sequences; the Philips images were the easiest to seg-
ment, believed to be due to postprocessing, which
eliminated background noise and accentuated the car-
tilage edges, aiding the livewire algorithm in segmenta-
tion. The Siemens and GE images appeared noisier,
although the Siemens DESS sequence provided super-
ior fluid-to-soft tissue contrast at the cartilage surface.
Formal assessment of image SNR could not be
performed because of the postprocessing of the Philips
images. These factors also may account for the under-
estimation of femoral-cartilage thickness on the GE
scanner due to more difficulties encountered delineat-
ing the cartilage-to-bone boundary.
A significant variation was found in the QA performed
at each site, with formal slice-thickness profile and geo-
metric distortion QA being available at the Philips site
only. It is possible that variations in the slice-thickness
profile between scanners may have contributed to the
interscanner variation because of differences in partial-
volume effects. These errors are considered to be most
frequent at sites of greater surface curvature at the
edges of the cartilage plates, which would have been
reduced by the trimming of the segmented cartilage sur-
faces in the image analysis.
Multivendor studies investigating cartilage morphology
have been performed previously by using MR scanners at
3.0T and lower field strengths [8,9]. Morgan et al.[ 8 ]
detected small systematic interscanner differences in
quantitative measurements of cartilage volume. Kornaat
et al. [9] performed a study with two 3.0T scanners man-
ufactured by Philips and GE. The principal difference of
our study is that the subjects are symptomatic. Accuracy
and precision of cartilage measurements in thinned carti-
lage is more challenging because of factors such as par-
tial-volume averaging and altered signal and structure in
pathologic tissues. Potential factors affecting variability
Figure 3 Mean cartilage thickness interscanner and intrascanner difference maps shown on the mean bone surfaces. Differences are
shown by using the same blue-to-red color scale for all comparisons, with red indicating thicker cartilage in the first compared with the second
scanner.
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pulse sequences, and so on. At 3.0T, factors such as B1
and B0 inhomogeneity play a greater role in interscanner
variability compared with 1.5T [25]. It is important to
emphasize that our study compared three specific scan-
ners, and the results cannot necessarily be generalized to
all scanners of a particular vendor. We aimed to investi-
gate the likely errors in a multivendor study, not to com-
pare the performances of different vendors’ products in
general.
Interscanner differences in knee-cartilage thicknesses
between Philips and GE 3.0T scanners have been mea-
sured by others in healthy subjects [9], where a mean
difference of 0.19 mm (up to a maximum of 0.88 mm
but not statistically significant) in the femoral-cartilage
thickness was reported. Similar to this study, the Philips
scanner used had an eight-channel phased-array knee
RF coil, and the GE scanner had a quadrature transmit-
receive coil. Hardware differences are inevitably encoun-
tered in other multicenter studies, as often only one RF
coil type is available, as was the case in this study.
Minimizing precision errors means that smaller differ-
ences can be detected in a group with a given number
of subjects. What represents a clinically significant dif-
ference in cartilage thickness in OA is still unclear and,
we hope, will be answered by the results of the NIH
OAI study. This study presents a method intended for
monitoring changes in groups of subjects with OA. Our
method incorporates a bone-modeling technique that
aims to facilitate image segmentation and analysis by
achieving anatomic correspondence between images.
The model was devised by using data from a training
set of images from Siemens scanners. We have shown
that this can be successfully applied to similar image
data from scanners of different vendors.
Conclusions
The study demonstrates that the Siemens NIH OAI pro-
tocol can be optimized for the Philips and GE 3T scan-
ners to achieve images of similar resolution and
contrast. However, in quantitative cartilage-thickness
analysis, significant interscanner differences may occur
in some cases. These may be due to a combination of
differences in extremity RF coil, challenges in sequence
optimization, and image postprocessing.
Overall, imaging at 3.0T improves intra- and interscan-
ner precision errors in comparison with imaging at lower
field strengths. This study supports the use of 3.0T scan-
ners from different manufacturers in clinical trials of OA
involving quantitative MR cartilage morphology after
investigation of interscanner precision errors. It is still
recommended, however, that longitudinal observations
on individuals be performed on the same scanner.
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